Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)Read more
Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD
The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)Read more
ImaBiotech provides quantitative MALDI Imaging Mass Spectrometry services unmatched by any other classical technique: quantitative, label-free ocular distribution with high accuracy up to 20µm resolution.
Traditional drug pharmacokinetics and distribution with dissection can now be replaced by MALDI Imaging Mass Spectrometry, which offers precise localization and quantitation of parent drugs and metabolites. No more LCMS/MS method development for the various ocular tissues!
CLICK A SPECIFIC REGION OF INTEREST FOR MORE INFORMATION
- High resolution drug +metabolites imaging at 20µm
- Quantify drug and metabolites in specific regions from the anterior to posterior chambers of the eye
- Unknown metabolite research and identification
- Dry eye
- Diabetic retinopathy
- Iridocorneal angle
- Sclera, choroid, retina
- Vitreous & Aqueous humor
- Optic nerve